BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Genetown

  Generation Bio Raises $100 Million Series B to Finance Non-Viral Gene Therapy Program

  Cambridge, Massachusetts-based Generation Bio closed on a $100 million Series B financing today.

  February 27, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Senti Biosciences Raises $53 Million from Amgen and Others in Series A Financing

  Senti Biosciences, based in South San Francisco, has completed a $53 million Series A financing.

  February 27, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Eli Lilly’s Verzenio Picks Up Third Approved Indication

  Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio.

  February 27, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  Everyday Networking Tips for the Life Sciences

  Networking can be a daunting process, but it is essential for career management.

  February 27, 2018

   · 

  4 min read

   · 

  Tina Baumgartner
• 

  Business

  Legal Ruling Means Pharma Bro Could Spend A Decade in Prison

  Martin Shkreli will be responsible for $10.4 million in financial losses when he faces sentencing for defrauding hedge fund investors on March 9.

  February 27, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Aldeyra Therapeutics Inks Collaboration Deal with Johnson & Johnson to Develop Anti-inflammatory Therapies

  Aldeyra Therapeutics has signed a collaboration research deal with Janssen Research & Development, a Johnson & Johnson company.

  February 27, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Incoming MassBio Chairman Eyes Improving Gender Diversity Across the State’s Life Sciences Industry

  David Lucchino, chief executive officer of Frequency Therapeutics, is expected to be named the next chairman of MassBio next month.

  February 27, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  DBV Technologies Reports Positive Data from Milk Allergy Trial

  French company DBV Technologies is seeing some positive results from its milk allergy treatment.

  February 27, 2018

   · 

  2 min read

   · 

  Alex Keown
• Poxel Presents Preclinical Proof-of-Concept Data for PXL770 in Non-Alcoholic Steatohepatitis (NASH) at Global NASH Congress 2018

  PXL770 is observed to significantly reduce liver steatosis and NAS score following eight weeks of treatment vs control

  February 27, 2018

   · 

  6 min read
• Biotech Bay

  Larvol Transforms Competitive Intelligence Space With Launch of KOL and Pharma Tracking Mobile App

  This new mobile experience offers users the ability to track new developments related to Key Opinion Leaders, pharmaceutical products, and clinical trials in real time on their smartphones.

  February 27, 2018

   · 

  2 min read